ID   PYRG_STAA1              Reviewed;         536 AA.
AC   A7X4X7;
DT   14-APR-2009, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 1.
DT   07-APR-2021, entry version 85.
DE   RecName: Full=CTP synthase {ECO:0000255|HAMAP-Rule:MF_01227};
DE            EC=6.3.4.2 {ECO:0000255|HAMAP-Rule:MF_01227};
DE   AltName: Full=Cytidine 5'-triphosphate synthase {ECO:0000255|HAMAP-Rule:MF_01227};
DE   AltName: Full=Cytidine triphosphate synthetase {ECO:0000255|HAMAP-Rule:MF_01227};
DE            Short=CTP synthetase {ECO:0000255|HAMAP-Rule:MF_01227};
DE            Short=CTPS {ECO:0000255|HAMAP-Rule:MF_01227};
DE   AltName: Full=UTP--ammonia ligase {ECO:0000255|HAMAP-Rule:MF_01227};
GN   Name=pyrG {ECO:0000255|HAMAP-Rule:MF_01227}; OrderedLocusNames=SAHV_2111;
OS   Staphylococcus aureus (strain Mu3 / ATCC 700698).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae;
OC   Staphylococcus.
OX   NCBI_TaxID=418127;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Mu3 / ATCC 700698;
RX   PubMed=17954695; DOI=10.1128/aac.00534-07;
RA   Neoh H.-M., Cui L., Yuzawa H., Takeuchi F., Matsuo M., Hiramatsu K.;
RT   "Mutated response regulator graR is responsible for phenotypic conversion
RT   of Staphylococcus aureus from heterogeneous vancomycin-intermediate
RT   resistance to vancomycin-intermediate resistance.";
RL   Antimicrob. Agents Chemother. 52:45-53(2008).
CC   -!- FUNCTION: Catalyzes the ATP-dependent amination of UTP to CTP with
CC       either L-glutamine or ammonia as the source of nitrogen. Regulates
CC       intracellular CTP levels through interactions with the four
CC       ribonucleotide triphosphates. {ECO:0000255|HAMAP-Rule:MF_01227}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + L-glutamine + UTP = ADP + CTP + 2 H(+) + L-
CC         glutamate + phosphate; Xref=Rhea:RHEA:26426, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29985, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:37563, ChEBI:CHEBI:43474, ChEBI:CHEBI:46398,
CC         ChEBI:CHEBI:58359, ChEBI:CHEBI:456216; EC=6.3.4.2;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01227};
CC   -!- ACTIVITY REGULATION: Allosterically activated by GTP, when glutamine is
CC       the substrate; GTP has no effect on the reaction when ammonia is the
CC       substrate. The allosteric effector GTP functions by stabilizing the
CC       protein conformation that binds the tetrahedral intermediate(s) formed
CC       during glutamine hydrolysis. Inhibited by the product CTP, via
CC       allosteric rather than competitive inhibition. {ECO:0000255|HAMAP-
CC       Rule:MF_01227}.
CC   -!- PATHWAY: Pyrimidine metabolism; CTP biosynthesis via de novo pathway;
CC       CTP from UDP: step 2/2. {ECO:0000255|HAMAP-Rule:MF_01227}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000255|HAMAP-Rule:MF_01227}.
CC   -!- MISCELLANEOUS: CTPSs have evolved a hybrid strategy for distinguishing
CC       between UTP and CTP. The overlapping regions of the product feedback
CC       inhibitory and substrate sites recognize a common feature in both
CC       compounds, the triphosphate moiety. To differentiate isosteric
CC       substrate and product pyrimidine rings, an additional pocket far from
CC       the expected kinase/ligase catalytic site, specifically recognizes the
CC       cytosine and ribose portions of the product inhibitor.
CC       {ECO:0000255|HAMAP-Rule:MF_01227}.
CC   -!- SIMILARITY: Belongs to the CTP synthase family. {ECO:0000255|HAMAP-
CC       Rule:MF_01227}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AP009324; BAF78994.1; -; Genomic_DNA.
DR   RefSeq; WP_000159960.1; NZ_CTYB01000015.1.
DR   SMR; A7X4X7; -.
DR   MEROPS; C26.964; -.
DR   GeneID; 59700931; -.
DR   KEGG; saw:SAHV_2111; -.
DR   HOGENOM; CLU_011675_5_0_9; -.
DR   OMA; EFNNAYR; -.
DR   BioCyc; SAUR418127:G1G2S-2356-MONOMER; -.
DR   UniPathway; UPA00159; UER00277.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003883; F:CTP synthase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0044210; P:'de novo' CTP biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW.
DR   CDD; cd03113; CTPS_N; 1.
DR   CDD; cd01746; GATase1_CTP_Synthase; 1.
DR   Gene3D; 3.40.50.880; -; 1.
DR   HAMAP; MF_01227; PyrG; 1.
DR   InterPro; IPR029062; Class_I_gatase-like.
DR   InterPro; IPR004468; CTP_synthase.
DR   InterPro; IPR017456; CTP_synthase_N.
DR   InterPro; IPR017926; GATASE.
DR   InterPro; IPR033828; GATase1_CTP_Synthase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11550; PTHR11550; 1.
DR   Pfam; PF06418; CTP_synth_N; 1.
DR   Pfam; PF00117; GATase; 1.
DR   SUPFAM; SSF52317; SSF52317; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00337; PyrG; 1.
DR   PROSITE; PS51273; GATASE_TYPE_1; 1.
PE   3: Inferred from homology;
KW   ATP-binding; Glutamine amidotransferase; Ligase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Pyrimidine biosynthesis.
FT   CHAIN           1..536
FT                   /note="CTP synthase"
FT                   /id="PRO_1000139583"
FT   DOMAIN          293..535
FT                   /note="Glutamine amidotransferase type-1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   NP_BIND         14..19
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   NP_BIND         148..150
FT                   /note="CTP; allosteric inhibitor"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   NP_BIND         188..193
FT                   /note="CTP; allosteric inhibitor; alternate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   NP_BIND         188..193
FT                   /note="UTP; alternate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   NP_BIND         240..242
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   REGION          1..267
FT                   /note="Amidoligase domain"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   REGION          383..386
FT                   /note="L-glutamine binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   ACT_SITE        382
FT                   /note="Nucleophile; for glutamine hydrolysis"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   ACT_SITE        508
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   ACT_SITE        510
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   METAL           71
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   METAL           141
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   BINDING         13
FT                   /note="CTP; allosteric inhibitor; alternate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   BINDING         13
FT                   /note="UTP; alternate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   BINDING         54
FT                   /note="L-glutamine"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   BINDING         71
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   BINDING         224
FT                   /note="CTP; allosteric inhibitor; alternate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   BINDING         224
FT                   /note="UTP; alternate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   BINDING         355
FT                   /note="L-glutamine; via carbonyl oxygen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   BINDING         406
FT                   /note="L-glutamine"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
FT   BINDING         463
FT                   /note="L-glutamine; via amide nitrogen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01227"
SQ   SEQUENCE   536 AA;  59992 MW;  615123D00BDD79E8 CRC64;
     MTKFIFVTGG VVSSLGKGIT ASSLGRLLKD RGLNVTIQKF DPYLNVDPGT MSPYQHGEVF
     VTDDGAETDL DLGHYERFID INLNKFSNVT AGKVYSHVLK KERRGDYLGG TVQVIPHITN
     EIKERLLLAG ESTNADVVIT EIGGTTGDIE SLPFIEAIRQ IRSDLGRENV MYVHCTLLPY
     IKAAGEMKTK PTQHSVKELR GLGIQPDLIV VRTEYEMTQD LKDKIALFCD INKESVIECR
     DADSLYEIPL QLSQQNMDDI VIKRLQLNAK YETQLDEWKQ LLDIVNNLDG KITIGLVGKY
     VSLQDAYLSV VESLKHAGYP FAKDIDIRWI DSSEVTDENA AEYLADVDGI LVPGGFGFRA
     SEGKISAIKY ARENNVPFFG ICLGMQLATV EFSRNVLGLE GAHSAELDPA TPYPIIDLLP
     EQKDIEDLGG TLRLGLYPCS IKEGTLAQDV YGKAEIEERH RHRYEFNNDY REQLEANGMV
     ISGTSPDGRL VEMVEIPTND FFIACQFHPE FLSRPNRPHP IFKSFIEASL KYQQNK
//
